Cyabra, Inc. (CYAB) is an AI-powered narrative-intelligence company that helps governments, defense agencies, and brands detect coordinated online manipulation and disinformation. The stock, which began trading on Nasdaq in late March after a SPAC merger, slid 16.17% to $0.0705 on Thursday, down from Wednesday's close of $0.0841. The decline extends a brutal three-session sequence that has erased the entirety of Monday's 53.7% surge. The immediate catalyst is a 30-for-1 reverse stock split announced Wednesday after the close, layered on top of dilution concerns tied to a large new financing package.
After Wednesday's close, Cyabra confirmed that a 30-for-1 reverse split of its common stock will be implemented at the market open on November 23, cutting roughly 38.4 million shares outstanding to about 1.28 million. The company will keep the CYAB symbol but trade under a new CUSIP number. The board approved the ratio on November 4 and stockholders ratified a discretionary 1-for-2 to 1-for-30 range at the annual meeting on November 10.
Management framed the step as a path to regaining compliance with Nasdaq's minimum bid price requirement. For traders, however, a split of this magnitude is a confirmation that the equity has fallen far below the $1 threshold and that the countdown on a listing deficiency is now explicit. Shares had already fallen 15.73% on Wednesday and 27% on Tuesday, so the announcement landed on an already fragile tape and accelerated the exit.
Monday's rally was triggered by an investment agreement covering up to $40 million over three years, including cancellation of roughly $3 million of debt. The initial closing comprises $15.6 million, split between $10 million in cash and $5.6 million of converted debt, issued as preferred stock convertible at $0.15 per share plus warrants, with a further $30 million tied to milestones.
That capital is essential — the company reported $1.34 million of cash, negative operating cash flow, and going-concern language in its filings — but it is enormous relative to a market capitalization now measured in low single-digit millions. Issuance of the underlying common shares requires stockholder approval, leaving investors to price in a substantially larger future share count. Preferred terms struck at multiples of the current share price have not prevented sellers from treating the structure as a supply problem.
Cyabra reported third-quarter results on Monday before the open, alongside the financing, and the stock more than doubled intraday before closing up 53.7% on roughly 430 million shares. That volume was hundreds of times a normal session. With no fresh operational news since, and only a Deloitte Technology Fast 500 ranking on Wednesday morning, the position has been driven by the mechanics of a crowded short-term trade rather than new fundamentals. Three consecutive declines is the classic profile of momentum capital leaving a micro-cap long after a single-day spike.
The decline was idiosyncratic. There was no broad software, cybersecurity, or small-cap selloff of comparable scale, and the pressure came directly from company announcements. Volume has moderated sharply from Monday's extreme: Wednesday turned over about 8.8 million shares, far above the sub-million-share sessions that were routine in early November but a fraction of the spike-day total. Liquidity remains thin, which amplifies percentage moves.
Technically, the shares slipped below the prior 52-week low near $0.075 and trade far beneath the 50-day moving average around $0.18, with a twelve-month decline of roughly 99%. Every rally attempt since midsummer has failed at lower highs.
The scale runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. The score here is 34 out of 100.
The verified news was moderate: a reverse split is a compliance action rather than an operating event, though it matters considerably for a company of this size and reinforces the dilution narrative. The price move was unusual but not extraordinary for this name. It was roughly 2.2 times the average absolute daily move of about 7.5% over the past 60 sessions, and four of those 60 sessions produced an equal or larger swing. Moderate news plus a moderately anomalous move combine into a mid-range score.
The near-term focus is November 23, when post-split trading begins and the share count falls to about 1.28 million, a change that often introduces erratic pricing around the effective date. A stockholder vote on issuing the common shares underlying the preferred conversion is the next major corporate checkpoint, and investors will also watch whether Nasdaq confirms a cure of the bid-price deficiency.
Third-quarter results are already in hand, so the next scheduled report is expected in mid-February. Analyst coverage is thin, with two firms carrying a Buy consensus, and estimates were last revised in September. Key risks include further capital raises, continued cash burn, execution on government and defense contract pipelines, and the possibility that post-split liquidity deters institutional participation. Upside would require evidence of durable revenue growth alongside a cleaner balance sheet.
Tickeron's Trending AI Robots page is a curated view of automated trading strategies built for exactly this kind of volatile tape. Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions appear in this section. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade. Reviewing the current leaders can help traders compare systematic approaches against their own read of the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Aroon Indicator for CYAB entered a downward trend on November 13, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 97 similar instances where the Aroon Indicator formed such a pattern. In 68 of the 97 cases the stock moved lower. This puts the odds of a downward move at 70%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYAB as a result. In 12 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 17%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CYAB's RSI Indicator exited the oversold zone, 10 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CYAB just turned positive on October 20, 2026. Looking at past instances where CYAB's MACD turned positive, the stock continued to rise in 9 of 42 cases over the following month. The odds of a continued upward trend are 21%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYAB advanced for three days, in 32 of 86 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
CYAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.130) is normal, around the industry mean (16.188). P/E Ratio (-0.061) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (0.671) is also within normal values, averaging (103.301).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. CYAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications